tirzepatide by lilly FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price Lilly escalates compounding challenge after

In rodent studies, GLP-1 receptor agonists caused thyroid C-cell tumors, including medullary thyroid carcinoma

Chronic pancreatitis Repeat bouts of acute pancreatitis can lead to chronic pancreatitis

While Ozempic is the brand name for the version approved for diabetes, other branded medications like Wegovy use the same active ingredient specifically for weight management

Energy drinks should be at the top of your "avoid" list, not just limited

A 2004 study by the University of Alabama found that the red blood cells in male Alzheimers patients showed a significant lack of glutathione

BCBS Michigan changed the prior authorization criteria for Zepbound (tirzepatide), Wegovy (semaglutide), and Saxenda (liraglutide) from August 1, 2024, through December 31, 2024